The effect of Medicare Part D on prescription drug spending and health care use: 6 Years of follow-up, 2007-2012

Journal of Managed Care and Specialty Pharmacy

Volumn 23, Issue 1, 2017, Pages 5-12

  Park, Taehwan ^a   Jung, Eah ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; MALE; MEDICARE; OUTPATIENT; PRESCRIPTION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; INSURANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DRUG COSTS; FEMALE; FINANCING, PERSONAL; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INSURANCE COVERAGE; MALE; MEDICARE PART D; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES;

EID: 85009445490     PISSN: 23760540     EISSN: 23761032     Source Type: Journal    
DOI: 10.18553/jmcp.2017.23.1.5     Document Type: Article

References (30)

1. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007;26(6):1735-44.
2. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148(3):169-77.
3. Chen H, Nwangwu A, Aparasu R, Essien E, Sun S, Lee K. The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psychiatr Serv. 2008;59(10):1191-97.
4. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008;14(11 Suppl):SP14-22.
5. Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52-61.
6. Joyce GF, Goldman DP, Vogt WB, Sun E, Jena AB. Medicare Part D after 2 years. Am J Manag Care. 2009;15(8):536-44.
7. Duggan M, Scott Morton F. The effect of Medicare Part D on pharmaceutical prices and utilization. Am Econ Rev. 2010;100(1):590-607.
8. Millett C, Everett CJ, Matheson EM, Bindman AB, Mainous AG. Impact of Medicare Part D on seniors' out-of-pocket expenditures on medications. Arch Intern Med. 2010;170(15):1325-30.
9. Briesacher BA, Zhao Y, Madden JM, et al. Medicare Part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care. 2011;49(9):834-41.
10. Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res. 2011;46(4):1104-23.
11. Nelson RE, Nelson SL, Huttner B, Gundlapalli A. The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities. Disabil Health J. 2014;7(1):64-69.
12. Kircher SM, Johansen ME, Nimeiri HS, Richardson CR, Davis MM. Impact of Medicare Part D on out-of-pocket drug costs and medical use for patients with cancer. Cancer. 2014;120(21):3378-84.
13. Polinski JM, Kilabuk E, Schneeweiss S, Brennan T, Shrank WH. Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review. J Am Geriatr Soc. 2010;58(9):1764-79.
14. Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA. 2009;302(16):1755-56.
15. Ayyagari P, Shane DM, Wehby GL. The impact of Medicare Part D on emergency department visits. Health Econ. Published online February 11, 2016. [Epub ahead of print]
16. Kaestner R, Long C, Alexander GC. Effects of prescription drug insurance on hospitalization and mortality: evidence from Medicare Part D. National Bureau of Economic Research. September 2014. Available at: http://economics.ucr.edu/seminars_colloquia/2014-15/applied_economics/ Kaestner_2-9-15.pdf. Accessed November 16, 2016.
17. Cohen JW, Cohen SB, Banthin JS. The Medical Expenditure Panel Survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47(7 Suppl 1):S44-50.
18. Mahmoudi E, Levy HG. How did Medicare Part D affect racial and ethnic disparities in drug coverage? J Gerontol B Psychol Sci Soc Sci. 2016;71(3):581-89.
19. Grootendorst PV, O'Brien BJ, Anderson GM. On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines. Med Care. 1997;35(4):386-98.
20. Dugoff EH, Schuler M, Stuart EA. Generalizing observational study results: applying propensity score methods to complex surveys. Health Serv Res. 2014;49(1):284-303.
21. Hartzema AG, Tilson HH, Chan KA. Pharmacoepidemiology and Therapeutic Risk Management. 1st ed. Cincinnati, OH: Harvey Whitney Books Company; 2008.
22. Garrido MM, Kelley AS, Paris J, et al. Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49(5):1701-20.
23. Cook BL, McGuire TG, Meara E, Zaslavsky AM. Adjusting for health status in non-linear models of health care disparities. Health Serv Outcomes Res Methodol. 2009;9(1):1-21.
24. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429-33.
25. Olsen MK, Schafer JL. A two-part random-effects model for semicontinuous longitudinal data. Amer Statist Assoc. 2001;96(454):730-45.
26. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-94.
27. Yau KKW, Wang K, Lee AH. Zero-inflated negative binomial mixed regression modeling of over-dispersed count data with extra zeros. Biom J. 2003;45(4):437-52.
28. Congressional Budget Office. Offsetting effects of prescription drug use on Medicare's spending for medical services. November 2012. Available at: https://www.cbo.gov/sites/default/files/cbofiles/attachments/43741-Medical-Offsets-11-29-12.pdf. Accessed November 16, 2016.
29. Kaiser Family Foundation. The Medicare prescription drug benefits. Fact sheet. September 2014. Available at: http://files.kff.org/attachment/medicareprescription-drug-benefit-fact-sheet. Accessed November 16, 2016.
30. Hill SC, Zuvekas SH, Zodet MW. Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry. 2011;48(3):242-59.